文献

J-GLOBAL ID：202002271914724432   整理番号：20A2681391

ダパグリフロジンは2型糖尿病患者の心室血行動態と運動誘発性肺高血圧症に影響する ランダム化比較試験

Dapagliflozin Influences Ventricular Hemodynamics and Exercise-Induced Pulmonary Hypertension in Type 2 Diabetes Patients - A Randomized Controlled Trial -

著者 (19件)： Kayano Hiroyuki (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Koba Shinji (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Hirano Tsutomu (Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine) ,  Matsui Taiju (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Fukuoka Hiroto (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Tsuijita Hiroaki (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Tsukamoto Shigeto (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Hayashi Toshiyuki (Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine) ,  Toshida Tsutomu (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Watanabe Norikazu (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Hamazaki Yuji (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Geshi Eiichi (Department of Internal Medicine, Showa University School of Nursing and Rehabilitation Sciences) ,  Murakami Mikitaka (Murakami Cardiology and Medical Clinic) ,  Aihara Kazuo (Aihara Medical Clinic) ,  Kaneko Koujin (Kaneko Clinic) ,  Yamada Hirokazu (Soiken Inc.) ,  Yamada Hirokazu (EviPRO Co., Ltd.) ,  Kobayashi Youichi (Department of Medicine, Division of Cardiology, Showa University School of Medicine) ,  Shinke Toshiro (Department of Medicine, Division of Cardiology, Showa University School of Medicine)
資料名： Circulation Journal  (Circulation Journal)
巻： 84  号： 10  ページ： 1807-1817(J-STAGE)  発行年： 2020年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景,この前向きランダム化多施設オープンラベル試験は,ナトリ...

シソーラス用語： ヒト ,...
準シソーラス用語： SGLT2阻害薬 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2681391&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者キーワード (4件)： 心臓機能 ,  ダパグリフロジン ,  心エコー検査 ,  運動

分類 (1件)： 代謝異常・栄養性疾患の治療  (GD05030F)

物質索引 (1件)： ダパグリフロジン

引用文献 (32件)：

• 1. Vazquez-Benitez G, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, et al. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: A contemporary analysis. Diabetes Care 2015; 38: 905-912.
• 2. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
• 3. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373: 2117-2128.
• 4. Mahaffey KW, Neal B, Perkovic V, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Circulation 2018; 137: 323-334.
• 5. Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2018; 373: 2117-2128.

タイトルに関連する用語 (8件)： ダパグリフロジン ,  2型糖尿病 ,  患者 ,  心室 ,  血行動態 ,  運動 ,  肺高血圧症 ,  ランダム化比較試験